Universe›Health Care›Pharmaceuticals
Observatory · observe first

Pharmaceuticals

Pharmaceuticals is gaining market weight. Gained weight for 1 consecutive month.

Historical time machine
Historical observation
20182026
Declining fasterConcentrated

Most of this industry's gains came from a few companies.

Universe weight
5.35%
$0.98T
12-month change
+2.06 pp
6-month change
-0.75 pp
3-month change
-0.45 pp
Company participation
50%
above their 6M weight average

Where did the weight change come from?

12-month contribution in universe percentage points · contributions add to the industry change

Company attribution
All other companies+1.379 pp
Industry total+2.055 pp

The three largest same-direction contributors explain 75% of gross gains. Opposing contributions can make an individual company’s change larger than the industry’s net change.

How has it moved through history?

Share of matched S&P 500 members

Jan 2018 – Aug 2019 · market weight (%)

3.44.76.020182019

Relative performance

Industry return versus ACWI · no future data shown

10111512820182019

Is participation broad or concentrated?

Actual constituent counts at this date, not the legacy synthetic breadth proxy

Above their 3M universe-weight average67%
Above their 6M universe-weight average50%
Above their 12M universe-weight average83%
Top 5 share of current industry market cap93.9%

This is size concentration, not contribution to the 12-month change. The attribution above measures the latter.

Evidence can disagree

Independent dimensions · no combined score or bullish/bearish verdict

Allocation · 12M+2.06 pp
Relative strength · 12M+2.9%
Price index return · 12M+2.9%
Earnings revisions · unavailable0.0
Allocation gained weight while relative performance rose. At least half of constituents are above their 6M weight average. These observations need not agree.
Other evidence and availability

Valuation data: unavailable; shown as zero placeholder.

Attention data: unavailable; shown as zero placeholder.

Actual fund flows: unavailable. No ETF, mutual-fund or institutional flow feed is connected.

Volume / turnover: unavailable in this dataset.

Follow the contribution to individual companies

Sorted by absolute 12-month weight contribution, not investment merit

CompanySub-industryCountryUniverse weight12M contribution12M price returnRevisions
Johnson & Johnson →
JNJ
PharmaceuticalsUnited States1.842%+0.676 pp-2.1%0.0
Merck & Co. →
MRK
PharmaceuticalsUnited States1.149%+0.587 pp+29.5%0.0
Pfizer →
PFE
PharmaceuticalsUnited States1.015%+0.269 pp-11.4%0.0
Lilly (Eli) →
LLY
PharmaceuticalsUnited States0.593%+0.227 pp+9.3%0.0
Zoetis →
ZTS
PharmaceuticalsUnited States0.328%+0.187 pp+40.4%0.0
Bristol Myers Squibb →
BMY
PharmaceuticalsUnited States0.428%+0.109 pp-18.0%0.0
Underlying monthly industry observations
MonthWeight1M change3M change6M change12M changeRelative return · 12M
Aug 20195.355%+0.109 pp-0.451 pp-0.747 pp+2.055 pp+2.9%
Jul 20195.246%-0.362 pp-0.491 pp+1.871 pp-0.528 pp+3.2%
Jun 20195.608%-0.198 pp-0.488 pp+1.949 pp+0.106 pp+15.3%
May 20195.806%+0.069 pp-0.296 pp+2.143 pp+0.395 pp+20.4%
Apr 20195.737%-0.360 pp+2.362 pp+2.198 pp+0.137 pp+13.3%
Mar 20196.097%-0.005 pp+2.437 pp+2.731 pp+0.496 pp+20.2%
Feb 20196.102%+2.727 pp+2.439 pp+2.802 pp+0.560 pp+21.4%
Jan 20193.375%-0.284 pp-0.164 pp-2.399 pp-2.125 pp+20.2%
Dec 20183.660%-0.003 pp+0.293 pp-1.843 pp-1.841 pp+29.5%
Nov 20183.663%+0.123 pp+0.363 pp-1.749 pp-1.837 pp+29.3%
Oct 20183.539%+0.173 pp-2.235 pp-2.061 pp-1.961 pp+22.7%
Sep 20183.366%+0.067 pp-2.136 pp-2.235 pp-2.134 pp+14.8%
Aug 20183.300%-2.475 pp-2.112 pp-2.242 pp-2.201 pp+11.7%
Jul 20185.774%+0.272 pp+0.174 pp+0.274 pp+0.274 pp+8.2%
Jun 20185.502%+0.091 pp-0.099 pp+0.002 pp+0.002 pp+2.0%
May 20185.411%-0.189 pp-0.130 pp-0.089 pp-0.089 pp-0.5%
Apr 20185.600%-0.001 pp+0.100 pp+0.100 pp+0.100 pp+1.2%
Mar 20185.601%+0.060 pp+0.101 pp+0.101 pp+0.101 pp+1.6%
Feb 20185.542%+0.042 pp+0.042 pp+0.042 pp+0.042 pp+1.2%
Jan 20185.500%+0.000 pp+0.000 pp+0.000 pp+0.000 pp+0.0%
How are these descriptive states defined?

Gaining / losing: 12-month weight change above +0.005pp / below −0.005pp. Direction and speed are separate dimensions, not mutually exclusive recommendations.

Accelerating / slowing: compare the most recent 3M change with the preceding 3M change. Accelerating means a positive change speeds up by >0.02pp. Slowing means the magnitude of movement declines by >0.02pp. A falling industry can also slow.

Reversing: the last two 3M changes have opposite signs, outside a ±0.005pp tolerance. Persistence counts consecutive same-direction monthly changes.

Broad / concentrated: company attribution, not a market-cap concentration shortcut. Concentrated means the three largest same-direction contributors account for ≥70% of gross same-direction changes; otherwise broad requires ≥60% of constituents moving with the industry. Other cases are mixed.

Weights use matched S&P 500 members’ market-cap estimates, based on SEC-reported shares available by each month-end and monthly closing prices. Companies without a matched price or share record are omitted, so the denominator is the matched sample rather than every index member. These are not official float-adjusted S&P weights. Flow is not measured.